TAZOQUIT-SB 375 Injection combines Ceftriaxone (250mg) and Sulbactam (125mg), a powerful antibiotic formulation designed to treat a wide range of bacterial infections. Ceftriaxone, a third-generation cephalosporin, offers strong bactericidal activity, while Sulbactam acts as a beta-lactamase inhibitor, enhancing Ceftriaxone’s efficacy against resistant strains.
Key Benefits:
-
Provides broad-spectrum antibacterial coverage
-
Effective against beta-lactamase-producing bacteria
-
Reduces the risk of treatment failure in resistant infections
-
Useful in respiratory, urinary, abdominal, and skin infections
-
Ensures quick relief and high patient safety profile
Indications:
-
Respiratory tract infections (pneumonia, bronchitis)
-
Urinary tract infections
-
Skin and soft tissue infections
-
Intra-abdominal and gynecological infections
-
Septicemia and bone infections
Dosage & Administration:
-
Dosage should be determined by the physician based on the severity of the infection.
-
Typically administered via intravenous (IV) or intramuscular (IM) injection.
-
Always follow healthcare professional guidance for preparation and administration.
Ingredients:
-
Ceftriaxone Sodium (250 mg) – Broad-spectrum antibiotic
-
Sulbactam Sodium (125 mg) – Beta-lactamase inhibitor
Storage:
-
Store below 25°C in a cool and dry place.
-
Protect from light and moisture.
-
Keep out of reach of children.
Why Choose TAZOQUIT-SB 375 Injection?
-
Trusted combination for effective infection management
-
Manufactured under strict quality control for purity and efficacy
-
Recommended by healthcare professionals for fast bacterial eradication
Reviews
There are no reviews yet.